Coronary imaging developer Infraredx has received a $25 million equity investment from Japanese firm Nipro.
The investment builds on Infraredx's exclusive agreement with Nipro for distribution of its true vessel characterization (TVC) intravascular imaging system in Japan, according to the firms. As part of the investment, a member of Nipro's management team will join Infraredx's board of directors.
The companies expect to receive Japanese regulatory approval for TVC in the first half of 2014.
